What if your vitamins actually matched your body?
Matt V
March 19, 2025
AI TECH
Most supplements take a one-size-fits-all approach, but our bodies don’t work that way.
Bioniq is shaking things up by using AI and blood biomarker data to create personalised supplements based on factors like age, weight, and lifestyle.
Athletes have taken notice.
Cristiano Ronaldo invested in Bioniq in 2024, pushing its valuation to $28 million.
Now, Manchester United’s Diogo Dalot has backed it with €1 million, helping fuel its expansion, particularly in the U.S. market.
Bioniq hasn’t shared its updated valuation, but the momentum is clear.
Founded in 2019 by Vadim Fedotov, Bioniq has built a massive biochemical database of blood test results from users in 70 countries, allowing it to create over 10 million unique supplement formulas.
Cristiano Ronaldo said yes, so did AI
Originally developed for Olympic athletes, the technology is now helping more people move from reactive health fixes to proactive care.
Dalot, a long-time Bioniq user, swears by its impact on his training.
The Build Your Own supplement lets him tweak his intake based on performance goals, whether that’s reducing inflammation or allowing just enough to aid muscle growth.
In brief:
AI-powered blood analysis builds supplement plans tailored to individual needs
Major athletes have invested, proving its credibility in high-performance sports
Pushing to bring personalised health solutions to a global audience
Bioniq has become a go-to for World Cup champions, NBA stars, and Ironman athletes.
With AI-driven precision and partnerships with UFC and Lanserhof, it’s making waves in the $177.5 billion supplement industry, which is expected to grow by 9.1% annually until 2030.
Bioniq is betting that the future of health is personal.
Maybe that multivit isn’t doing anything after all…